OPKO Health, Inc. is 10% Owner at GeneDx Holdings Corp. (WGS). They have made 27 open-market trades across 3 companies since 2013, most recently 2024-08-19.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $14.0M since 2017, against 25 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 72% | 64% | 60% |
| Avg Move | -15.7% | +0.9% | +41.2% |
| Scored | 25 | 25 | 25 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WGS | SELL | 2024-08-15 | 2024-08-19 | $33.92 | $7.8M | -8.4% | +9.3% | +100.5% |
| WGS | SELL | 2024-08-12 | 2024-08-14 | $34.19 | $5.8M | +3.9% | +10.5% | +124.5% |
| WGS | SELL | 2024-08-06 | 2024-08-08 | $31.31 | $3.9M | +4.4% | +2.7% | +131.3% |
| WGS | SELL | 2024-07-31 | 2024-08-02 | $33.50 | $6.0M | +30.9% | +18.9% | +216.0% |
| WGS | SELL | 2024-07-29 | 2024-07-31 | $33.86 | $1.7M | +1.2% | -3.4% | +154.1% |
| WGS | SELL | 2024-07-24 | 2024-07-26 | $33.78 | $4.6M | -13.2% | +6.1% | +76.2% |
| WGS | SELL | 2024-07-19 | 2024-07-23 | $32.98 | $4.9M | -8.9% | +3.1% | +76.3% |
| WGS | SELL | 2024-07-17 | 2024-07-19 | $32.93 | $823K | +1.5% | +10.2% | +73.7% |
| WGS | SELL | 2024-07-05 | 2024-07-09 | $28.24 | $2.0M | +3.4% | +6.7% | +71.4% |
| WGS | SELL | 2024-07-01 | 2024-07-03 | $27.67 | $2.9M | +14.5% | +7.4% | +53.7% |
| WGS | BUY | 2023-01-26 | 2023-01-31 | $0.35 | $10.0M | -10.2% | +1.1% | -44.3% |
| VBIV | BUY | 2017-10-30 | 2017-11-01 | $3.05 | $4.0M | +10.8% | +26.1% | +5.3% |
| SRNE | SELL | 2013-11-25 | 2013-11-27 | $8.54 | $178K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-22 | 2013-11-25 | $8.50 | $72K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-21 | 2013-11-22 | $8.53 | $36K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-19 | 2013-11-21 | $8.75 | $149K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-15 | 2013-11-18 | $8.75 | $24K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-14 | 2013-11-15 | $8.75 | $17K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-13 | 2013-11-14 | $8.75 | $118K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-08 | 2013-11-12 | $8.75 | $18K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-11-06 | 2013-11-08 | $9.03 | $1.1M | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-09-04 | 2013-09-04 | $7.75 | $73K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-08-29 | 2013-08-30 | $7.75 | $775 | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-08-26 | 2013-08-28 | $7.93 | $18K | -28.1% | -3.2% | -3.2% |
| SRNE | SELL | 2013-08-20 | 2013-08-21 | $7.78 | $12K | -28.1% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.